Is pancreatic giant cell tumor resistant to standard chemotherapy?
dc.contributor.author | Caglayan, Dilek | |
dc.contributor.author | Eryilmaz, Melek Karakurt | |
dc.contributor.author | Korkmaz, Mustafa | |
dc.contributor.author | Karaagac, Mustafa | |
dc.contributor.author | Hendem, Engin | |
dc.contributor.author | Artac, Mehmet | |
dc.date.accessioned | 2024-02-23T14:21:05Z | |
dc.date.available | 2024-02-23T14:21:05Z | |
dc.date.issued | 2022 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Pancreatic giant cell tumors (PGCTs), undifferentiated pancreatic carcinoma are rare tumors of the pancreas. PGCTs consist of osteoclastic, pleomorphic and mixed variants. PGCT is usually diagnosed at an advanced stage. PGCT has a worse prognosis than pancreatic ductal adenocarcinoma. Although surgery can be curative, there is no standard treatment approach for advanced PGCT. We present a case of PGCT that is resistant to standard therapy and progresses in a short time. | en_US |
dc.identifier.doi | 10.1097/CAD.0000000000001331 | |
dc.identifier.endpage | 760 | en_US |
dc.identifier.issn | 0959-4973 | |
dc.identifier.issn | 1473-5741 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 35946539 | en_US |
dc.identifier.scopus | 2-s2.0-85136848702 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 758 | en_US |
dc.identifier.uri | https://doi.org/10.1097/CAD.0000000000001331 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/13443 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000841282200007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Anti-Cancer Drugs | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Folfirinox | en_US |
dc.subject | Giant Cell Tumors | en_US |
dc.subject | Pancreas | en_US |
dc.subject | Resistant | en_US |
dc.title | Is pancreatic giant cell tumor resistant to standard chemotherapy? | en_US |
dc.type | Article | en_US |